Skip to main content
Premium Trial:

Request an Annual Quote

FDA to Use GVKBio’s Biomarker DB in Voluntary Exploratory Data Program

NEW YORK (GenomeWeb News) - GVK Biosciences today said it has inked an agreement that will give the US Food and Drug Administration access to the company’s Clinical Biomarker Database.
 
Under the agreement, the FDA will use the database as part of its Voluntary Exploratory Data Submission Program and in internal research projects.
 
The database holds information from published literature relating to clinical and pre-clinical biomarkers, and may be used in biomarker design and validation research, the company said.
 
GVK Bio, which is headquartered in Hyderabad, India, has a US base in Columbia, Md.
 
Financial terms of the agreement were not released.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.